Linden Thomas Advisory Services’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,734
Closed -$444K 541
2025
Q4
$444K Sell
1,734
-93
-5% -$24.4K 0.05% 396
2025
Q3
$475K Buy
1,827
+25
+1% +$6.57K 0.05% 392
2025
Q2
$441K Buy
1,802
+1
+0.1% +$249 0.05% 393
2025
Q1
$477K Buy
1,801
+154
+9% +$41.6K 0.06% 383
2024
Q4
$418K Sell
1,647
-118
-7% -$31.6K 0.05% 401
2024
Q3
$559K Sell
1,765
-12
-0.7% -$4.27K 0.08% 364
2024
Q2
$664K Sell
1,777
-1,711
-49% -$578K 0.1% 319
2024
Q1
$1.21M Hold
3,488
0.19% 221
2023
Q4
$1.6M Sell
3,488
-14
-0.4% -$6.9K 0.3% 122
2023
Q3
$1.7M Sell
3,502
-155
-4% -$72.8K 0.38% 67
2023
Q2
$1.64M Buy
3,657
+13
+0.4% +$6.54K 0.36% 82
2023
Q1
$1.77M Buy
3,644
+80
+2% +$39.5K 0.44% 59
2022
Q4
$1.83M Buy
+3,564
New +$1.87M 0.51% 43

Other funds holding HUM

Linden Thomas Advisory Services's HUM Position: Q1 2026 in Review

Linden Thomas Advisory Services sold out of Humana (HUM) in Q1 2026, closing a stake of 1,734 shares — an estimated $444K sold.

Linden Thomas Advisory Services first reported a position in HUM in Q4 2022 and held it in 13 quarters. The position peaked at $1.83M in Q4 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Linden Thomas Advisory Services reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • Linden Thomas Advisory Services sold 1,734 Humana shares in Q1 2026, an estimated $444K.
  • Linden Thomas Advisory Services first reported a position in Humana in Q4 2022 and held it in 13 quarters.
  • Linden Thomas Advisory Services's Humana position peaked at $1.83M in Q4 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q1 2026, filed 10 Apr 2026.